Related Experiment Videos
[Telomeres and telomerase in leukemias]
1Kliniki Hematologii Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.
Przeglad Lekarski
|March 1, 2000
Summary
Telomere shortening acts as a cellular clock, leading to senescence. Telomerase activity, often found in tumors and normal hematopoietic cells, can stabilize telomeres and is explored for leukemia diagnostics, prognosis, and therapy.
Area of Science:
- Cellular Biology
- Molecular Biology
- Oncology
Context:
- Telomere shortening is a key indicator of cellular aging and senescence.
- Telomerase activity is crucial for telomere maintenance and is dysregulated in many cancers.
- Normal hematopoietic cells express telomerase, unlike most somatic cells.
Purpose:
- To review the diagnostic and prognostic utility of telomere length and telomerase activity in leukemia.
- To discuss the potential of anti-telomerase therapies for cancer treatment.
- To present findings on telomere length in young allogeneic transplant recipients.
Summary:
- Telomere shortening serves as a cellular clock, triggering senescence. Cancer cells often bypass this by reactivating telomerase, an enzyme that elongates telomeres.
- This review examines the role of telomere length and telomerase activity in leukemia diagnostics and prognosis.
- The potential of targeting telomerase in cancer therapy and telomere length in transplant recipients is also discussed.
Impact:
- Provides insights into telomere biology and its implications for cancer.
- Highlights the potential of telomere-based diagnostics and therapeutics for leukemia.
- Contributes to understanding telomere dynamics in transplantation settings.